A comparative study of the use of selective digestive decontamination prophylaxis in living‐donor liver transplant recipients

Bacterial infections are major causes of early morbidity and mortality after liver transplantation. Selective digestive decontamination (SDD) can be used pre‐operatively for living‐donor liver transplant (LD‐LT), but its role in this setting remains controversial.

[1]  K. Gurusamy,et al.  Methods of preventing bacterial sepsis and wound complications after liver transplantation. , 2014, The Cochrane database of systematic reviews.

[2]  N. Selzner,et al.  Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C. , 2012, Transplantation proceedings.

[3]  J. A. Kaan,et al.  Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. , 2011, The Lancet. Infectious diseases.

[4]  D. Gouma,et al.  Influence of Prophylactic Probiotics and Selective Decontamination on Bacterial Translocation in Patients Undergoing Pancreatic Surgery: A Randomized Controlled Trial , 2011, Shock.

[5]  M. Mizumoto,et al.  Posttransplant bacteremia in adult living donor liver transplant recipients , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  H. Van Vlierberghe,et al.  Antimicrobial prophylaxis in liver transplant patients – a multicenter survey endorsed by the European Liver and Intestine Transplant Association , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  J. A. Kaan,et al.  Decontamination of the digestive tract and oropharynx in ICU patients. , 2009, The New England journal of medicine.

[8]  L. Baddour,et al.  Incidence Rate and Outcome of Gram‐Negative Bloodstream Infection in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  S. Kim,et al.  Infectious complications in living‐donor liver transplant recipients: a 9‐year single‐center experience , 2008, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[11]  M. Malago',et al.  Pulmonary and Blood Stream Infections in Adult Living Donor and Cadaveric Liver Transplant Patients , 2008, Transplantation.

[12]  B. Gridelli,et al.  Selective decontamination of the digestive tract in adult-to-adult living related liver transplant patients: a single centre experience. , 2008, International journal of antimicrobial agents.

[13]  J. Fishman Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.

[14]  M. Milanese,et al.  Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. , 2007, The Journal of hospital infection.

[15]  A. Humar,et al.  American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  T. Chiba,et al.  Biliary complications after a right-lobe living donor liver transplantation , 2005, Journal of Gastroenterology.

[17]  D. Cook,et al.  Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia , 2004, Annals of Internal Medicine.

[18]  N. Safdar,et al.  The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: A systematic review and meta‐analysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  D. Zandstra,et al.  Selective decontamination of the digestive tract: Rationale behind evidence‐based use in liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  Larry J. Anderson,et al.  Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, Respiratory care.

[21]  P. Bossuyt,et al.  Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial , 2003, The Lancet.

[22]  H. Bruining,et al.  Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients , 2002, Critical care medicine.

[23]  Teresa C. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.

[24]  A. Burroughs,et al.  Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation , 1998, Transplant international : official journal of the European Society for Organ Transplantation.

[25]  V. Torri,et al.  Selective decontamination of digestive tract , 1991, The Lancet.

[26]  Acip Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[27]  T. Horan,et al.  Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.

[28]  M. Gilchrist Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.